As of 2025-02-17, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 706.21 USD. This relative valuation is based on P/E multiples. With the latest stock price at 673.60 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is 4.8%.
The range of the Relative Valuation is 674.08 - 773.92 USD.
Range | Selected | |
Trailing P/E multiples | 16.7x - 17.4x | 17.0x |
Forward P/E multiples | 15.6x - 17.9x | 16.8x |
Fair Price | 674.08 - 773.92 | 706.21 |
Upside | 0.1% - 14.9% | 4.8% |
Date | P/E |
2025-02-14 | 16.69 |
2025-02-13 | 16.70 |
2025-02-12 | 16.45 |
2025-02-11 | 16.49 |
2025-02-10 | 17.10 |
2025-02-07 | 17.59 |
2025-02-06 | 17.89 |
2025-02-05 | 17.76 |
2025-02-04 | 17.27 |
2025-02-03 | 16.52 |
2025-01-31 | 16.67 |
2025-01-30 | 16.92 |
2025-01-29 | 17.03 |
2025-01-28 | 17.00 |
2025-01-27 | 16.96 |
2025-01-24 | 16.74 |
2025-01-23 | 17.21 |
2025-01-22 | 16.85 |
2025-01-21 | 17.04 |
2025-01-17 | 16.89 |
2025-01-16 | 17.17 |
2025-01-15 | 17.43 |
2025-01-14 | 17.12 |
2025-01-13 | 17.76 |
2025-01-10 | 17.26 |
2025-01-08 | 18.17 |
2025-01-07 | 18.09 |
2025-01-06 | 17.74 |
2025-01-03 | 17.79 |
2025-01-02 | 17.72 |
2024-12-31 | 17.65 |
2024-12-30 | 17.41 |
2024-12-27 | 17.65 |
2024-12-26 | 17.76 |
2024-12-24 | 17.70 |
2024-12-23 | 17.72 |
2024-12-20 | 17.39 |
2024-12-19 | 17.55 |
2024-12-18 | 17.70 |
2024-12-17 | 18.33 |
2024-12-16 | 17.96 |
2024-12-13 | 18.12 |
2024-12-12 | 18.36 |
2024-12-11 | 19.15 |
2024-12-10 | 19.29 |
2024-12-09 | 19.52 |
2024-12-06 | 19.27 |
2024-12-05 | 19.02 |
2024-12-04 | 18.69 |
2024-12-03 | 18.57 |